Literature DB >> 23733763

Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation.

Javier Munoz1, Ellen Schlette, Razelle Kurzrock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23733763     DOI： 10.1200/JCO.2012.45.7739

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  28 in total

Review 1.  Hairy cell leukemia: update and current therapeutic approach.

Authors:  Latif Salam; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

2.  A tale of two histiocytic disorders.

Authors:  Filip Janku; Javier Munoz; Vivek Subbiah; Razelle Kurzrock
Journal:  Oncologist       Date:  2013-01-08

Review 3.  [Hairy cell leukemia].

Authors:  S Dietrich; M Andrulis; T Zenz
Journal:  Internist (Berl)       Date:  2015-04       Impact factor: 0.743

Review 4.  The National Clinical Trials Network: Conducting Successful Clinical Trials of New Therapies for Rare Cancers.

Authors:  Anne F Schott; John J Welch; Claire F Verschraegen; Razelle Kurzrock
Journal:  Semin Oncol       Date:  2015-07-10       Impact factor: 4.929

Review 5.  The evidence framework for precision cancer medicine.

Authors:  Jeffrey A Moscow; Tito Fojo; Richard L Schilsky
Journal:  Nat Rev Clin Oncol       Date:  2017-12-19       Impact factor: 66.675

6.  Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.

Authors:  Eszter Sári; Zsolt György Nagy; Kornélia Baghy; Hajnalka Rajnai; Csaba Bödör; Judit Csomor; Gábor Barna; Gábor Rudas; Ilona Kovalszky; Judit Demeter
Journal:  Pathol Oncol Res       Date:  2014-05-03       Impact factor: 3.201

7.  Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Authors:  Michael R Grever; Omar Abdel-Wahab; Leslie A Andritsos; Versha Banerji; Jacqueline Barrientos; James S Blachly; Timothy G Call; Daniel Catovsky; Claire Dearden; Judit Demeter; Monica Else; Francesco Forconi; Alessandro Gozzetti; Anthony D Ho; James B Johnston; Jeffrey Jones; Gunnar Juliusson; Eric Kraut; Robert J Kreitman; Loree Larratt; Francesco Lauria; Gerard Lozanski; Emili Montserrat; Sameer A Parikh; Jae H Park; Aaron Polliack; Graeme R Quest; Kanti R Rai; Farhad Ravandi; Tadeusz Robak; Alan Saven; John F Seymour; Tamar Tadmor; Martin S Tallman; Constantine Tam; Enrico Tiacci; Xavier Troussard; Clive S Zent; Thorsten Zenz; Pier Luigi Zinzani; Brunangelo Falini
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

Review 8.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

9.  BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.

Authors:  Svetlana A Protsenko; Anna I Semionova; Yuri I Komarov; Svetlana N Aleksakhina; Alexandr O Ivantsov; Aglaya G Iyevleva; Evgeny N Imyanitov
Journal:  Invest New Drugs       Date:  2015-08-20       Impact factor: 3.850

10.  Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia.

Authors:  Stephen S Chung; Eunhee Kim; Jae H Park; Christopher Y Park; Omar Abdel-Wahab; Young Rock Chung; Piro Lito; Julie Teruya-Feldstein; Wenhuo Hu; Wendy Beguelin; Sebastien Monette; Cihangir Duy; Raajit Rampal; Leon Telis; Minal Patel; Min Kyung Kim; Kety Huberman; Nancy Bouvier; Michael F Berger; Ari M Melnick; Neal Rosen; Martin S Tallman
Journal:  Sci Transl Med       Date:  2014-05-28       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.